Pancreatic beta cells and GABA-ergic neurons express the synthesizing enzyme for the inhibitory neurotransmitter GABA, glutamic acid decarboxylase. Pancreatic alpha cells and perhaps also delta cells express GABA/A receptors and GABA may function as a paracrine signaling molecule for communication among the endocrine cells in the pancreas. GAD is encoded by two distinct genes, GAD65 and GAD67, which differ mainly in the first 100 amino acids but share extensive homology in the remainder of the proteins. Human beta cells only express GAD65 and this form of the enzyme is a target of autoantibodies associated with early and late phases of beta cell destruction resulting in type 1 diabetes. Furthermore GAD65 has been shown to be an important T-cell autoantigen in the NOD-mouse model of type 1 diabetes. This project examines the role of GAD65 and GAD67, and GABA in islet cell development, function and beta cell autoantigenicity focusing on the cell biology of the GAD proteins and use of transgenic mouse models of aberrant GAD and GABA expression.
The first aim i s to characterize the topology of the GAD65 molecule which is synthesized as a hydrophilic soluble molecule, but is post- translationally modified and processed to become anchored to the membrane of synaptic like microvesicles.
The second aim i s to characterize the signaling and targeting sequences and the modification(s) that confer the subcellular localization of GAD65.
The third aim i s to characterize transgenic mouse models of over expression of GAD65 in beta cells and the consequences of such expression on islet cell development, function and autoantigenicity.
The fourth aim i s to generate transgenic mouse models over-expressing GAD65 late in development, and examine the consequences for tolerance development and autoantigenicity. The fifth aim is to characterize the islet cell and neurological function of GAD65 knock out mice and the consequences of rescue by wild type and mutant forms of GAD65. The overall goal is to elucidate the molecular mechanisms of function, subcellular localization and autoantigenicity of the GABA-ergic system in the pancreas.

Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
1996
Total Cost
Indirect Cost
Wilson, Maria E; Scheel, David; German, Michael S (2003) Gene expression cascades in pancreatic development. Mech Dev 120:65-80
Sander, M; Paydar, S; Ericson, J et al. (2000) Ventral neural patterning by Nkx homeobox genes: Nkx6.1 controls somatic motor neuron and ventral interneuron fates. Genes Dev 14:2134-9
Roll, U; Turck, C W; Gitelman, S E et al. (2000) Peptide mapping and characterisation of glycation patterns of the glima 38 antigen recognised by autoantibodies in Type I diabetic patients. Diabetologia 43:598-608
Sander, M; Sussel, L; Conners, J et al. (2000) Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development 127:5533-40
Shi, Y; Kanaani, J; Menard-Rose, V et al. (2000) Increased expression of GAD65 and GABA in pancreatic beta-cells impairs first-phase insulin secretion. Am J Physiol Endocrinol Metab 279:E684-94
Kanaani, J; Lissin, D; Kash, S F et al. (1999) The hydrophilic isoform of glutamate decarboxylase, GAD67, is targeted to membranes and nerve terminals independent of dimerization with the hydrophobic membrane-anchored isoform, GAD65. J Biol Chem 274:37200-9
Schwartz, H L; Chandonia, J M; Kash, S F et al. (1999) High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase. J Mol Biol 287:983-99
Smith, S B; Ee, H C; Conners, J R et al. (1999) Paired-homeodomain transcription factor PAX4 acts as a transcriptional repressor in early pancreatic development. Mol Cell Biol 19:8272-80
Bridgett, M; Cetkovic-Cvrlje, M; O'Rourke, R et al. (1998) Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells. Diabetes 47:1848-56
Damert, A; Machein, M; Breier, G et al. (1997) Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res 57:3860-4

Showing the most recent 10 out of 27 publications